Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.00%
#4 aPriori aPriori +152.64%
#5 Bedrock Bedrock +71.59%
#6 Cysic Cysic +51.82%
#7 Prom Prom +46.77%
#8 Playnance Playnance +34.96%
#9 Bitway Bitway +28.81%
#10 COTI COTI +27.28%
Coin of the day
Wrapped One Wrapped One
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Classificação em ações #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Preço da ação
$0.00023723
Última sincronização: 2024-08-26
Valor de mercado
$1.41K
Variação (1 dia)
111.67%
Variação (1 ano)
0.00%
País
FR
Negociar Pharnext S.A. (ALPHA)

Categoria

Healthcare
Receita da Pharnext S.A. (ALPHA)
Receita em Dec 2023 TTM: $-487.61K
De acordo com os últimos relatórios financeiros da Pharnext S.A., a receita atual da empresa (TTM) é $-487.61K. Em 2022, a empresa obteve uma receita de $598.55 uma diminuição em relação a a receita do ano 2021, que foi de $96.41K. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Pharnext S.A. de 2013 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $-487.61K -4,510.88%
2023 $11.05K 1,746.90%
2022 $598.55 -99.38%
2021 $96.41K 98.76%
2020 $48.51K -82.90%
2019 $283.61K -96.39%
2018 $7.85M 96.92%
2017 $3.99M -14.33%
2016 $4.65M 62.80%
2015 $2.86M -14.35%
2014 $3.34M -7.92%
2013 $3.62M 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -2,589,130.69%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -1,234,964.32%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -2,073,651.57%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR